Login to Your Account

Other News To Note

Thursday, December 29, 2011
• Alnylam Pharmaceuticals Inc., of Cambridge, Mass., reported preclinical data published in Experimental Neurology showing that a small interfering RNA (siRNA) targeting the huntingtin gene resulted in widespread distribution of the siRNA when administered by intrastriatal infusion using convection-enhanced delivery and demonstrated significant silencing of the huntingtin mRNA throughout the striatum.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription